Announcing EX Program Go from Truth Initiative: A Scalable Digital Tobacco Cessation Solution for Small to Mid-Sized Employers

WASHINGTON, July 10, 2025 /PRNewswire/ — The team behind EX Program, the leading digital tobacco cessation solution developed by Truth Initiative in collaboration with Mayo Clinic, today announced the launch of EX Program Go — a scalable, low-cost program designed specifically for small to mid-sized employers. As part of the EX Program Enterprise suite, EX Program Go helps organizations support employees with nicotine addiction by providing a proven path to quitting, while also reducing healthcare costs. Launching nationwide, the program comes at a critical time, as more than 49 million U.S. adults still use tobacco and access to free quit resources continues to shrink due to funding cuts.

EX Program Go highlights include:

  • 15 user licenses of EX Program
  • Proactive promotional support (English and Spanish)
  • A digital dashboard with real-time metrics
  • Compliance with reasonable alternative standard requirements for tobacco surcharges
  • A simple annual fee of $6,000 with easy online purchasing options via credit card

EX Program Go clients — defined as employers with fewer than 2,500 employees — can be up and running in less than two weeks, with dedicated Client Success support for launch and annual optimization.

“EX Program Go is the right fit for small to mid-sized employers that view tobacco cessation as a strategic decision to reduce healthcare costs and improve workplace productivity,” said Dr. Amanda Graham, Chief Health Officer at Truth Initiative. “The program is proven to deliver $1,910 in healthcare and productivity savings per participant in the first year. That’s not just good health — it’s good business.”

Designed for Impact and Growth

EX Program Go is built on the same clinically-backed foundation as EX Program for large employers, health plans, and public health organizations. A recent third-party evaluation showed a 4.75x return on investment (ROI) in healthcare savings within the first year of implementation.

“In today’s marketplace, finding effective, scalable solutions that small to mid-sized employers can afford is challenging,” said Gretchen Day, Vice President of Health Innovation Advanced Strategies at Alera Group. “EX Program is an evidence-based program with validated results and a clear return on investment. EX Program Go is a more cost-effective solution designed specifically to support small to mid-size employers with the health and well-being of their employees.”

EX Program Go is now available for purchase.

For more information on EX Program, please visit theexprogram.com. For more information about Truth Initiative, please visit truthinitiative.org.

About EX Program
Developed with Mayo Clinic, EX® Program by Truth Initiative provides real results through personalized support for tobacco users for the behavioral, social, and physical aspects of addiction. EX Program includes a tailored quit plan; live chat coaching with experts; the longest-running and largest community of current and former tobacco users; dynamic text messaging; and quit medication delivered to the participant’s home. Clients receive real-time reporting about program performance through an interactive dashboard, proactive promotions, an expert client success manager, and more. Visit theexprogram.com for details.

View original content to download multimedia:https://www.prnewswire.com/news-releases/announcing-ex-program-go-from-truth-initiative-a-scalable-digital-tobacco-cessation-solution-for-small-to-mid-sized-employers-302502709.html

SOURCE Truth Initiative

Staff

Recent Posts

Atropos Health Appoints Kevin Smith to Chief Growth Officer to Accelerate Expansion of AI-Driven Real-World Evidence

PALO ALTO, Calif.--(BUSINESS WIRE)--Atropos Health, the pioneer in translating real-world clinical data into personalized real-world…

1 hour ago

Black Book Research Publishes the 2026 State of Global Digital Healthcare Technology

A landmark, vendor-agnostic global benchmark delivering country-true insights on EHR and digital health performance across…

2 hours ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Engagement reinforces CDT’s strategy to unlock value from its solid-form asset portfolioNAPLES, Fla. and CAMBRIDGE,…

2 hours ago

As Flu Surge Continues, Polyrizon’s Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated

Raanana, Israel, Jan. 02, 2026 (GLOBE NEWSWIRE) -- As the 2025-2026 flu season intensifies across…

2 hours ago

Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer

WESTLAKE VILLAGE, Calif., Jan. 02, 2026 (GLOBE NEWSWIRE) --  Genelux Corporation (NASDAQ: GNLX), a late…

2 hours ago